Neogenomics Inc

VANGUARD GROUP INC NEO

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

13,828,355

Value ($000)

162,621

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	162,621	0.0%	13,828,355	12/31/2025
2025 Q3	11/7/2025	107,337	0.0%	13,903,735	9/30/2025
2025 Q2	8/11/2025	103,296	0.0%	14,130,761	6/30/2025
2025 Q1	5/9/2025	135,300	0.0%	14,257,116	3/31/2025
2024 Q4	2/11/2025	234,673	0.0%	14,239,887	12/31/2024
2024 Q3	11/13/2024	207,150	0.0%	14,044,094	9/30/2024
2024 Q2	8/13/2024	195,865	0.0%	14,121,490	6/30/2024
2024 Q1	5/10/2024	223,397	0.0%	14,211,019	3/31/2024
2023 Q4	3/11/2024	229,265	0.0%	14,169,665	12/31/2023
2023 Q3	12/18/2023	176,089	0.0%	14,316,201	9/30/2023
2023 Q2	8/14/2023	235,278	0.0%	14,640,814	6/30/2023
2023 Q1	7/14/2023	241,486	0.0%	13,870,557	3/31/2023
2022 Q4	2/10/2023	126,355	0.0%	13,674,745	12/31/2022
2022 Q3	11/14/2022	113,434	0.0%	13,174,708	9/30/2022
2022 Q2	8/12/2022	108,530	0.0%	13,316,401	6/30/2022
2022 Q1	5/13/2022	157,592	0.0%	12,970,503	3/31/2022
2021 Q4	2/14/2022	438,680	0.0%	12,856,969	12/31/2021
2021 Q3	11/12/2021	611,218	0.0%	12,670,362	9/30/2021
2021 Q2	8/13/2021	550,964	0.0%	12,197,560	6/30/2021
2021 Q1	5/14/2021	580,141	0.0%	12,028,639	3/31/2021
2020 Q4	2/12/2021	601,262	0.0%	11,167,578	12/31/2020
2020 Q3	11/16/2020	401,465	0.0%	10,882,750	9/30/2020
2020 Q2	8/14/2020	348,234	0.0%	11,240,602	6/30/2020
2020 Q1	5/15/2020	297,571	0.0%	10,777,645	3/31/2020
2019 Q4	2/14/2020	307,506	0.0%	10,513,003	12/31/2019
2014 Q2	8/11/2014	2,599	0.0%	782,749	6/30/2014
2014 Q1	5/13/2014	2,891	0.0%	832,878	3/31/2014
2013 Q4	2/12/2014	2,472	0.0%	682,793	12/31/2013